Safety and efficacy of Nonpeghylated Liposomal Doxorubicin (Myocet) in R-CHOP for the treatment of non Hodgkin's lymphoma in patients with high risk cardiac disease
Phase of Trial: Phase IV
Latest Information Update: 07 Sep 2016
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Cyclophosphamide; Prednisone; Rituximab; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 07 Sep 2016 New trial record.